 Stock analysts at Jefferies Financial Group initiated coverage on shares of Moderna NASDAQ:MRNA in a research report issued on Monday, Briefing.com Automated Import reports. The firm set a buy rating and a 90.00 price target on the stock. Jefferies Financial Groups price target points to a potential upside of 43.75 from the companys current price. ... 